MedCana has announced that it is actively analyzing opportunities to enter the Australian pharmaceutical cannabis market. With Australia's medicinal cannabis industry expected to grow substantially, the Australian legal cannabis market size is expected to reach USD 540.6 million by 2030, registering a CAGR of 27.8% from 2024 to 2030.
According to the latest reports, Australia's medicinal cannabis industry is poised for significant growth. This is driven by increasing patient demand, favorable regulatory changes, and expanding access to medicinal cannabis treatments. This dynamic market presents a ripe opportunity for companies like MedCana to bring their expertise in high-quality, pharmaceutical-grade cannabis products to the region.
MedCana's CEO, Gabriel Diaz, commented on the company's potential entry into Australia: "The growing demand for high-quality pharmaceutical cannabis has created a perfect moment for MedCana to expand quickly, not only as an exporter but also as a licensed holder within the country. We are excited about the possibilities that lie ahead and are committed to building strong partnerships within Australia."
For more information: 
Medcana
medcana.net